Drug Profile
Cholera and typhoid vaccine - Berna Biotech
Latest Information Update: 10 Jul 2002
Price :
$50
*
At a glance
- Originator Berna Biotech
- Developer Nonindustrial source
- Class Bacterial vaccines; Cholera vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cholera; Typhoid
Most Recent Events
- 10 Jul 2002 Discontinued - Clinical-Phase-Unknown for Cholera in Austria (PO)
- 10 Jul 2002 Discontinued - Clinical-Phase-Unknown for Typhoid in Austria (PO)
- 24 Jul 2001 The Swiss Serum and Vaccine Institute Berne is now called Berna Biotech